3M, Northrop Grumman Get $15.8M to Develop MDx for Biological Weapons | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 3M and Northrop Grumman are receiving funding from the US Department of Health and Human Services to develop molecular diagnostics as countermeasures against biological weapons.

The awards are two of eight contracts that were announced by HHS' Biomedical Advanced Research and Development Authority earlier this week that total more than $100 million. 3M will receive $6 million, while Northrop Grumman will get $9.8 million under the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.